Facial paralysis after superficial parotidectomy: analysis of possible predictors of this complication  by Bittar, Renato Fortes et al.
Braz J Otorhinolaryngol. 2016;82(4):447--451
www.bjorl.org
Brazilian Journal of
OTORHINOLARYNGOLOGY
ORIGINAL ARTICLE
Facial  paralysis  after  superﬁcial  parotidectomy:
analysis of  possible  predictors  of this  complication
Renato Fortes Bittar ∗, Homero Penha Ferraro, Marcelo Haddad Ribas,
Carlos  Neutzling Lehn
Hospital  do  Servidor  Público  Estadual  (IAMSPE),  São  Paulo,  SP,  Brazil
Received  9  June  2015;  accepted  25  August  2015
Available  online  19  December  2015
KEYWORDS
Salivary  gland
neoplasms;
Parotidectomy;
Superﬁcial
parotidectomy;
Facial  nerve;
Facial  paralysis
Abstract
Introduction:  Salivary  gland  tumors  represent  3--10%  of  all  head  and  neck  neoplasms.  These
tumors occur  predominantly  in  major  salivary  glands.  The  parotid  gland  is  affected  most  often,
ranging  from  36.6%  to  83%.  The  pleomorphic  adenoma  comprises  45--60%  of  all  salivary  gland
tumors. Several  surgical  approaches  have  been  described  to  treat  this  tumor.  Lesion  of  the
facial nerve  is  one  of  the  most  serious  complications  that  can  occur  after  parotid  gland  surgery.
Objectives:  To  determine  possible  predictive  factors  related  to  the  occurrence  of  peripheral
facial paralysis  (PFP)  after  superﬁcial  parotidectomy  in  the  surgical  treatment  of  the  pleomor-
phic adenomas  of  the  parotid  gland.
Methods:  This  was  a  primary,  observational,  case-control  study  performed  through  the  revision
of patients’  charts  and  histopathological  reports.  Data  was  obtained  from  1995  to  2014.  The
analyzed events  were:  tumor’s  length  and  depth;  duration  of  the  disease  referred  by  the  patient
(more than  1,  5  or  10  years);  primary  or  secondary  surgical  approach.
Results: The  analysis  showed  that  tumor  lengths  equal  or  superior  to  3.0  cm  were  a  risk  factor  of
PFP with  an  odds  ratio  of  3.98  (p  =  0.0310).  Tumor  depths  equal  or  superior  to  2.0  cm  were  also
a risk  factor  with  an  odds  ratio  of  9.5556  (p  =  0.0049|).  When  the  tested  event  was  secondary
surgery to  recurrent  tumors  we  have  found  an  odds  ratio  of  6.7778  (p  =  0.0029).
Conclusion:  Tumors  with  3.0  cm  or  more  in  length  and/or  2.0  cm  or  more  in  depth  have  a  signif-
icant higher  risk  of  facial  nerve  injury.  Secondary  surgery  to  recurrent  tumors  also  has  a  much
higher risk  of  evolving  with  facial  palsy  after  superﬁcial  parotidectomy.
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Paralisia  facial  após  parotidectomia  superﬁcial:  análise  de  possíveis  preditivos  dessa
complicac¸ão
Resumo
Introduc¸ão:  Os  tumores  de  glândulas  salivares  representam  de  3  a  10%  de  todas  as  neoplasias  de
cabec¸a e  pescoc¸o.  Esses  tumores  ocorrem  predominantemente  nas  glândulas  salivares  maiores.
A glândula  parótida  é  afetada  na  maioria  das  vezes,  variando  de  36,6  a  83%.  O  adenoma  pleomór-
ﬁco abrange  45--60%  de  todos  os  tumores  de  glândulas  salivares.  Diversas  abordagens  cirúrgicas
foram descritas  para  o  tratamento  desse  tumor.  A  lesão  do  nervo  facial  é  uma  das  complicac¸ões
mais graves  que  podem  ocorrer  após  cirurgia  de  glândula  parótida.
Objetivos:  Determinar  possíveis  fatores  preditivos  relacionados  à  ocorrência  de  paralisia  facial
periférica (PFP)  após  parotidectomia  superﬁcial  no  tratamento  cirúrgico  de  adenomas  pleomór-
ﬁcos de  glândula  parótida.
Método:  Estudo  preliminar,  observacional,  de  caso-controle,  realizado  por  meio  de  revisão
dos prontuários  de  pacientes  e  laudos  histopatológicos.  Os  dados  foram  obtidos  no  período
de 1995--2014.  Os  eventos  analisados  foram  o  tamanho  do  tumor  no  maior  diâmetro  e  a  pro-
fundidade,  o  tempo  de  doenc¸a  referido  pelo  paciente  (mais  de  1,  5  ou  10  anos)  e  a  abordagem
cirúrgica primária  ou  secundária.
Resultados:  A  análise  mostrou  que  o  tamanho  do  tumor  igual  ou  superior  a  3,0  cm  foi  um  fator  de
risco para  PFP,  com  um  razão  de  chance  de  3,98  (p  =  0,0310).  A  profundidade  do  tumor  igual  ou
superior a  2,0  cm  também  foi  um  fator  de  risco,  com  uma  razão  de  chance  de  9,5556  (p  =  0,0049).
Quando o  evento  testado  foi  cirurgia  secundária  para  tumores  recorrentes,  encontramos  uma
razão de  chance  de  6,7778  (p  =  0,0029).
Conclusão:  Os  tumores  de  3,0  cm  ou  mais  de  comprimento  e/ou  2,0  cm  ou  mais  de  profundidade
apresentam  um  risco  signiﬁcativamente  maior  de  lesão  do  nervo  facial.  A  cirurgia  secundária
para tumores  recorrentes  também  apresenta  um  risco  maior  de  evoluir  com  paralisia  facial  após
parotidectomia  superﬁcial.
© 2015  Associac¸a˜o  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Ce´rvico-Facial.  Publicado
por Elsevier  Editora  Ltda.  Este e´  um  artigo  Open  Access  sob  uma  licenc¸a  CC  BY  (http://
creativecommons.org/licenses/by/4.0/).
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alivary  gland  tumors  represent  3--10%  of  all  head  and  neck
eoplasms.1 These  tumors  occur  predominantly  in  major
alivary  glands.2,3
The  parotid  gland  is  affected  most  often,  ranging  from
6.6%  to  83%.  Malignant  tumors  are  a  minority,  occurring  in
5--32%  of  cases.1,4,5
The  most  common  malignant  and  benign  tumors  are  the
ucoepidermoid  carcinoma  and  the  pleomorphic  adenoma,
espectively.6,7
The  pleomorphic  adenoma  comprises  45--60%  of  all  sali-
ary  gland  tumors.  Approximately  80%  occur  in  the  parotid
land,  usually  in  the  inferior  pole  of  the  superﬁcial  lobe;
owever,  less  frequently,  it  can  occur  at  the  deep  lobe  or  in
he  accessory  parotid  tissue.8
Several  surgical  approaches  have  been  described
o  treat  this  tumor.  In  1895,  Senn  described  enu-
leation  as  the  technique  of  choice.  However,  tumor
emoval  was  incomplete  with  an  unacceptable  rate  of
ecurrence.9
Total  parotidectomy  removes  all  gland  tissue  lateral  and
edial  to  facial  nerve,  whereas  superﬁcial  parotidectomy
emoves  parotid  gland  lateral  to  the  facial  nerve.  In  extra-
apsular  dissection,  it  is  not  performed  any  dissection  of  the
acial  nerve.8,10--14
5
d
l
mLesion  of  the  facial  nerve  is  one  of  the  most  serious
omplications  that  can  occur  in  parotid  gland  surgery.  It  is
stimated  that  30--65%  of  all  patients  experience  some  sort
f  transient  facial  weakness,  and  3--6%  evolve  with  perma-
ent  dysfunction  resulting  in  signiﬁcant  impact  in  the  quality
f  life.14
The  main  purpose  of  this  study  was  to  determine  possible
redictive  factors  related  to  the  occurrence  of  peripheral
acial  paralysis  after  superﬁcial  parotidectomy  in  the  surgi-
al  treatment  of  the  pleomorphic  adenomas  of  the  parotid
land.
ethods
his  was  a  primary,  observational,  case-control  study
erformed  through  the  revision  of  patients’  charts
nd  histopathological  reports.  Data  was  obtained  from
995  to  2014.  Patient’s  names  were  not  retrieved;  all
nformation  was  obtained  through  hospital’s  registration
umbers.
The  analyzed  events  were:  tumor’s  length  and  depth;
uration  of  the  disease  referred  by  the  patient  (more  than  1, or  10  years);  primary  or  secondary  surgical  approach.  The
imensions  evaluated  were  obtained  from  the  histopatho-
ogical  reports  and  not  from  the  clinical  staging,  to  give  a
ore  precise  value.
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House-brackmann scale
Chart 1. Facial paralysis grade versus elapsed time until complete recovery.
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Table  1  Case-control  table  --  tumor’s  length.
Facial  paralysis
Length  Yes  No
≥3.0  cm  10  27
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(Figure  1  Facial  paralysis  grade  versus  elapsed  time  until  com-
plete  recovery.
We  divided  the  patients  into  groups  according  to  the  stud-
ied  event:
Tumor  length
Event  analyzed:  tumor  length  ≥0.5  cm,  1.0  cm,  1.5  cm,
2.0  cm,  2.5  cm  or  ≥3.0  cm.
Outcome:  Peripheral  facial  paralysis.
Cases:  Patients  who  underwent  superﬁcial  parotidectomy
with  tumor  length  greater  than  previously  referred  meas-
ures.
Controls:  Patients  who  underwent  superﬁcial  parotidec-
tomy  with  tumor  length  smaller  than  previously  referred
measures.
Tumor  depth
Event  analyzed:  tumor  depth  ≥0.5  cm,  1.0  cm,  1.5  cm  or
2.0  cm.
Outcome: Peripheral  facial  paralysis.
Cases:  Patients  who  underwent  superﬁcial  parotidectomy
with  tumor  depth  greater  than  previously  referred  meas-
ures.
Controls:  Patients  who  underwent  superﬁcial  parotidec-
tomy  with  tumor  depth  smaller  than  previously  referred
measures.
Recurrence  of  the  disease
Event  analyzed:  secondary  surgery  to  treat  recurrent  tumor.
Outcome:  Peripheral  facial  paralysis.
Cases:  Patients  who  underwent  superﬁcial  parotidectomy
with  a  recurrence  of  the  tumor  from  previous  surgery.
Controls:  Patients  who  underwent  superﬁcial  parotidec-
tomy  for  a  primary  tumor.
Duration  of  the  diseaseEvent  analyzed:  Time  referred  by  the  patient  from  the
moment  the  lesion  was  noticed  until  surgical  treatment.
Outcome:  Peripheral  facial  paralysis.
d
d
r<2.9 cm  4  43
Cases: Patients  with  duration  of  the  disease  superior  to
,  5  or  10  years.
Controls: Patients  with  duration  of  the  disease  inferior
o  1,  5  or  10  years.
Facial  paralysis  was  classiﬁed  and  graduated  according  to
ouse-Brackmann’s  scale  (HBS).  Patients  were  evaluated  at
he  ﬁrst  and  seventh  postoperative  days;  ﬁrst,  third  and  sixth
onths  after  surgery.  And,  in  the  ﬁrst  year  after  surgery.
All  patients  whose  charts  and  histopathological  reports
id  not  fulﬁll  these  criteria  were  excluded  from  the  study.
atients  who  have  had  any  kind  of  facial  motricity  impair-
ent  previous  to  surgery  were  also  excluded.
Data  was  then  analyzed  to  calculate  odds  ratio,  conﬁ-
ence  interval,  z-statistic,  and  signiﬁcance  level  (p  <  0.05).
esults
uring  the  studied  period  219  patients  were  submitted  to
urgical  approach  in  the  parotid  gland;  157  were  due  to
leomorphic  adenoma.
After  excluding  those  submitted  to  total  parotidectomy
nd  those  whose  information  was  incomplete  there  was  a
otal  of  84  patients  who  underwent  superﬁcial  parotidec-
omy.
Males  were  28  patients  and  females,  56.  The  average
ge  was  56.7  years  (17--89).  Average  length  was  2.892  cm
0.8--6.0  cm)  and  average  depth  was  1.880  cm  (0.5--3.2  cm).
he  right  side  was  affected  in  46  cases,  and  the  left  side,  in
8  cases.
Facial  paralysis  occurred  in  14  out  of  84  patients
16.66%),  four  males  and  ten  females.
Facial  paralysis  was  graded  according  to  HBS.  Five
atients  had  an  HBS  II,  seven  HBS  III  and  two  HBS  IV.  None
as  classiﬁed  as  HBS  V  or  VI.
Time  elapsed  from  initial  paralysis  to  complete  recovery
as  evaluated  in  weeks.  One  patient  with  HBS  II  had  full
ecovery  within  two  weeks.  On  the  other  hand,  an  HBS  IV
atient  had  full  recovery  only  on  the  36th  week.  No  patient
emained  with  facial  paralysis  after  36  weeks.  Medium  time
ntil  full  recovery  was  19.19  weeks  (Fig.  1).
To  evaluate  tumor’s  dimensions  several  values  were
equentially  tested  in  a  0.5  cm  interval.  Regarding  tumor’s
ength  we  have  found  no  statistical  signiﬁcance  when
umor’s  length  was  less  than  2.5  cm;  however,  when  a  3.0  cm
utoff  point  was  set  up  we  have  found  an  odds  ratio  of  3.98
ith  a  conﬁdence  interval  of  1.1345--13.9728  (p  =  0.0310)
Table  1).
The  same  was  done  with  tumor’s  depth,  and  with  a  2.0  cm
epth  we  have  found  an  odds  ratio  of  9.5556  with  a  conﬁ-
ence  interval  of  1.9832--46.0422  (p  =  0.0049)  (Table  2).
When  the  tested  event  was  secondary  surgery  to  recur-
ent  tumors  we  have  found  an  odds  ratio  of  6.7778  with
450  
Table  2  Case-control  table  --  tumor’s  depth.
Facial  paralysis
Depth  Yes  No
≥2.0  cm  12  27
<1.9 cm  2  43
Table  3  Case-control  table  --  primary  versus  secondary
surgery.
Facial  paralysis
Yes No
Secondary  7  9
Primary  7  61
Table  4  Case-control  table  --  duration  of  the  disease  (1
year).
Facial  paralysis
Yes  No
≥1  year  12  57
<1 year  2  13
Table  5  Case-control  table  --  duration  of  the  disease  (5
years).
Facial  paralysis
Yes  No
≥5  year  0  11
<5 year  14  59
Table  6  Case-control  table  --  duration  of  the  disease  (10
years).
Facial  paralysis
Yes  No
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<10 year  14  66
 conﬁdence  interval  of  1.9227  to  23.8928  (p  = 0.0029)
Table  3).
Considering  the  duration  of  the  disease,  the  evaluated
arameters  were  more  than  1,  5  and  10  years.  We  have
ound  odds  ratios  of  1.3684  with  a  conﬁdence  interval  of
.2725--6.8709  (p  =  .7032),  0.1784  with  a  conﬁdence  interval
f  0.0099--3.2072  (p  =  0.2423),  and  0.5096  with  a  conﬁ-
ence  interval  of  0.0260--9.9975  (p  =  0.6571),  respectively
Tables  4--6).
iscussionhis  was  a  retrospective,  case-control  study  that  analyzed
 signiﬁcant  number  of  patients  and  used  the  pleomorphic
denoma’s  clinical  and  morphological  features  to  determine
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ossible  predictive  factors  of  facial  paralysis  after  superﬁ-
ial  parotidectomy.
To  the  best  of  our  knowledge,  we  have  found  no  previous
imilar  study  in  the  reviewed  literature.
The  exclusion  of  doubtful  data  and  the  usage  of  measures
btained  from  high  quality  clinical  and  histopathological
eports  made  the  evaluation  very  precise  and  reliable.
In  this  study,  the  surgeries  were  performed  by  residents
nder  the  strict  supervision  of  a senior  Head  and  Neck
urgeon.  Patients  with  larger  and/or  deeper  or  recurrent
umors  were  operated  by  senior  surgeons.
This  may  be  considered  a  bias  of  the  study  since  more
han  one  surgeon  performed  the  surgeries;  however,  this  fact
eﬂects  best  the  reality  of  most  medical  residence  centers  in
razil.  Therefore,  this  information  could  be  useful  to  predict
nd  best  prevent  this  undesirable  outcome  by  the  hands  of
raining  residents.
Intraoperative  neural  monitoring  (IONM)  was  not  rou-
inely  used  due  to  hospital’s  limitation  quota.  Therefore,
ts  use  was  reserved  to  recurrent  tumors.
Females  were  56  cases,  and  males,  28.  Of  the  14  patients
ith  postoperative  facial  paralysis,  10  were  females  and  four
ere  males.  No  permanent  lesions  were  reported,  and  all
atients  were  fully  recovered  within  36  weeks.  No  severe
acial  paralysis  (HBS  V  or  VI)  was  also  reported  during  the
tudied  period.
Transient  facial  palsy  remains  the  most  common  compli-
ation  in  parotid  gland  tumor14 and  an  important  factor  of
istress  both  to  patients  and  the  surgical  team.  Permanent
alsy  is  seen  in  0--19%  of  the  cases.15--21
If  the  lesion  is  permanent  the  consequences  are  tremen-
ous,  resulting  in  possible  cornea  ulcers,  facial  asymmetry,
ysphasia,  and  drooling.
Superﬁcial  parotidectomy  remains  the  most  efﬁcient
echnique  yet  available,  allowing  the  surgeon  through  the
omplete  facial  nerve  dissection,  with  better  chances  of
reserving  its  function.22
It  is  still  a  matter  of  debate  whether  the  incidence  of
acial  paralysis  is  higher  after  malignant  tumors  resection,
ue  to  a  more  aggressive  surgical  approach,23 or  after  benign
esions,  usually  with  a  longer  duration  of  the  disease,  asso-
iated  with  tumor’s  adherence  and  adjacent  inﬂammatory
rocess.19
It  is  quite  intuitive  to  relate  the  increase  of  tumor’s
imension  to  a  higher  incidence  of  complications.  In  this
tudy,  we  have  demonstrated  that  tumors  with  3.0  cm  or
ore  in  length  and  2.0  cm  or  more  in  depth  have  a  signif-
cant  risk  of  evolving  with  facial  paralysis.  This  should  be
aken  into  account  in  the  pre-operative  evaluation,  and  con-
equently,  demand  a  much  more  careful  technique  during
erve  dissection.
All  of  the  16  cases  of  recurrence  occurred  after  enucle-
tion  of  the  lesion  performed  elsewhere,  since  this  approach
s  not  preconized  at  our  institution.  As  seen  in  this  study,  the
econdary  surgery  has  a  much  higher  risk  of  resulting  in  facial
alsy,  surely  due  to  perilesional  inﬂammation,  ﬁbrosis  and
ack  of  anatomical  landmarks.
Surgery  performed  after  a  previous  approach  of  the
arotid  gland  has  an  odds  ratio  of  6.7778  with  a  conﬁdence
nterval  of  1.9227--23.8928  (p  =  0.0029).  This  should  be  rec-
gnized  when  performing  the  primary  surgery,  demanding
 curative  approach  to  avoid  a  secondary  and,  therefore,
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more  risky  surgery  and  during  the  secondary  surgery  itself,
since  the  risks  of  facial  nerve  injury  are  signiﬁcantly  higher.
On  the  other  hand,  duration  of  the  disease  had  no  correla-
tion  with  a  higher  risk  of  facial  nerve  injury  during  superﬁcial
parotidectomy.  The  calculated  odds  ratios  were  1.3684  with
a  conﬁdence  interval  of  0.2725--6.8709  (p  =  0.7032);  0.1784
with  a  conﬁdence  interval  of  0.0099--3.2072  (p  =  0.2423),
and  0.5096  with  a  conﬁdence  interval  of  0.0260--9.9975
(p  =  0.6571),  with  1,  5  or  10  years  of  disease,  respectively.
One  might  expect  to  ﬁnd  a  higher  risk  of  facial  nerve
injury  with  longer  disease  period.  The  explanation  why  that
was  not  found  in  this  study  remains  unclear.  Further  studies
focusing  at  how  the  microscopic  ultrastructure  of  tumor’s
boundaries  changes  over  time  might  raise  more  information
on  this  matter.
Conclusion
Facial  nerve  injury  during  superﬁcial  parotidectomy  remains
the  most  common  and  most  feared  complication.
In  this  study,  we  have  found  that  tumors  with  3.0  cm
or  more  in  length  and/or  2.0  cm  or  more  in  depth  have  a
signiﬁcant  higher  risk  of  facial  nerve  injury.
Secondary  surgery  to  recurrent  tumors  also  has  a  much
higher  risk  of  evolving  with  facial  palsy  after  superﬁcial
parotidectomy.
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